Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Change in Accured Expenses (2009 - 2026)

Revvity's (RVTY) quarterly Change in Accured Expenses came in at -$4.2 million in Q3 2026, up 70.84% on a YoY basis from -$2.5 million in Q3 2025, and up 94.39% quarter-over-quarter from -$74.7 million in Q2 2026.

Analysis

Revvity (RVTY) Change in Accured Expenses (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Change in Accured Expenses for 18 consecutive years, with -$4.2 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Change in Accured Expenses rose 70.84% year-over-year to -$4.2 million; the trailing twelve-month figure through Jul 2026 stood at -$47.6 million (down 169.14% YoY), and the FY2025 full-year result was -$17.9 million, up 16.41% from the prior year.
  • Change in Accured Expenses improved to -$4.2 million in Q3 2026 per RVTY's latest filing, from -$74.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $92.8 million in Q4 2024 and bottomed at -$133.7 million in Q3 2023.
  • Historically, Change in Accured Expenses has averaged -$37.0 million across 5 years, with a median of -$39.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses surged 197.74% in 2024, then slumped 114.56% in 2026.
  • Over 5 years, Change in Accured Expenses stood at -$105.5 million in 2022, then soared by 129.56% to $31.2 million in 2023, then soared by 197.74% to $92.8 million in 2024, then sank by 44.95% to $51.1 million in 2025, then sank by 108.2% to -$4.2 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$4.2 million, -$74.7 million, and $51.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -249.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 34.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 23.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -4.19 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 3.53 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 12.13 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.12 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -91.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 -4.19 Mn
Apr 5, 2026 -74.69 Mn
Dec 28, 2025 51.11 Mn
Sep 28, 2025 -19.81 Mn
Jun 29, 2025 -14.37 Mn
Mar 30, 2025 -34.81 Mn
Dec 29, 2024 92.84 Mn
Sep 29, 2024 -61.34 Mn
Jun 30, 2024 -7.99 Mn
Mar 31, 2024 -44.91 Mn
Dec 31, 2023 31.18 Mn
Oct 1, 2023 -82.71 Mn
Jul 2, 2023 -133.69 Mn
Apr 2, 2023 -106.59 Mn
Jan 1, 2023 -77.17 Mn
Apr 3, 2022 -105.48 Mn
Oct 3, 2021 -11.23 Mn
Jul 4, 2021 -31.34 Mn
Apr 4, 2021 -116.88 Mn
Jan 3, 2021 286.77 Mn